|
Princeton Invention #
99-1608
Researchers in
the Chemistry Department at Princeton University have developed novel
metalloporphyrins that offer new potential pharmaceuticals for the treatment of
diseases such as diabetes, ischemia-reperfusion injury, stroke, inflammation,
neurodegeneration, and sepsis in which active oxygen (ROS)...
Published: 3/15/2018
|
Inventor(s): John Groves, Suzanne Moeller
Keywords(s):
Category(s): Biotechnology/Pharmaceuticals
|